Article

A pan-human coronavirus recombinant vaccine designed from conserved structural epitopes to counter emerging SARS-CoV-2 variants

2026-01-05

Abstract excerpt

Despite the global decline in COVID-19 incidence, approximately 50,000 active cases persist worldwide, and the continued emergence of immune-evasive SARS-CoV-2 variants, including BA.2.86 and JN.1, underscores the need for next-generation vaccines with broad and durable protection. In this study, we designed a recombinant multiepitope human coronavirus vaccine using an immunoinformatics-driven strategy to target c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: be16ee72-e5a8-54ca-8a46-ebe064940e9a
DOI: 10.22541/au.176763313.32711060/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A pan-human coronavirus recombinant vaccine designed from conserved structural epitopes to counter emerging SARS-CoV-2 variantsDOI 10.22541/au.176763313.32711060/v1Read

The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity Read

Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity Read

Identification of promising SARS-CoV-2 CD8+ and CD4+ T cell epitopes by immunoinformatics approach for a multi-epitope-based vaccine designSemantic proximity Read

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validationSemantic proximity Read

Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.Semantic proximity Read

An Immunoinformatic Approach for Identifying and Designing Conserved Multi-Epitope Vaccines for CoronavirusesSemantic proximity Read

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read

Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope EngineeringSemantic proximity Read

Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale ImmunitySemantic proximity Read

Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silicoSemantic proximity Read

Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniquesSemantic proximity Read

Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric VaccineSemantic proximity Read